Background. Nonoccupational postexposure prophylaxis (nPEP) is recommended after a sexual or parenteral exposure to human immunodeficiency virus (HIV). Patients frequently seek care in an emergency department (ED) after an exposure and are usually referred to an HIV clinic for further management. There have been few data on determinants of attrition after presentation to EDs for nPEP.
Nonoccupational postexposure prophylaxis (nPEP) is a recommended intervention to prevent human immunodeficiency virus (HIV) transmission after a sexual or percutaneous exposure if antiretroviral drugs can be initiated within 72 hours. Although no prospective randomized trials have been conducted, data from animal models and a large retrospective case-controlled study in occupational settings [1] have demonstrated the efficacy of postexposure prophylaxis (PEP). In addition, observational cohort studies have demonstrated the efficacy of nPEP [2, 3] . HIV transmission after nonoccupational exposures is uncommon with the use of nPEP, with most incident infections due to poor adherence to antiretroviral therapy (ART) and higher-risk exposures [2] .
Several barriers prevent patients from receiving appropriate care even before contact with the medical system, including a general lack of awareness of HIV postexposure prevention strategies [4, 5] and failure of the source patient to be aware of their HIV serostatus or disclose their status (if known) to the exposed individual [3] . Individuals who ultimately seek care after a potential HIV exposure have poor ART completion rates, often owing to gastrointestinal side effects [6] . Other factors may contribute to poor adherence, such as pill burden, cost of health care, and medical or psychiatric comorbid conditions. Attempts to mitigate these barriers to adherence have been largely unsuccessful because nPEP completion rates are still quite low even when 2-drug regimens [7] or newer and better-tolerated agents such as raltegravir are used [8] .
Patients often seek nPEP in emergency departments (EDs) after a potential HIV exposure. Typically, patients are evaluated by the ED physician and those deemed to have an exposure are provided with a few days of ART to bridge them to an outpatient clinic appointment, where they are evaluated by either a primary care provider or infectious diseases specialist. At the clinic, the decision is made to continue or stop ART. Clinic appointments are invaluable because they enable patients to receive a prescription to complete 28 days of ART (if necessary) and receive appropriate screening, counseling, and follow-up testing for HIV and other infections potentially related to the exposure in question (eg, other sexually transmitted infections, hepatitis B and C). Patients deemed to have a significant HIV exposure should be followed up for up to 6 months to confirm negative HIV serology [9] . Our clinical observations were that many individuals who were given nPEP in the ED and counseled to follow up at the clinic failed to attend the initial clinic appointment despite written and verbal instructions from the ED and telephone reminders (with interpreter services when required) provided by the clinic. We designed a prospective observational cohort study to determine risk factors for failing to follow up at the clinic after HIV exposures, with the aim of improving the quality of care for patients after a nonoccupational HIV exposure.
METHODS

Study Design
Ethical permission for this prospective observational cohort study at the Massachusetts General and Brigham and Women's Hospitals (both in Boston) was granted by the institutional review board of Partners Healthcare. All participants were older than 18 years and were deemed candidates for nPEP by a boardcertified infectious diseases physician abiding by current nPEP guidelines.
From July 2010 to June 2011, we prospectively recorded all referrals to nPEP programs from 2 large EDs at 2 academic medical centers in Boston. According to the nPEP protocol at our hospitals, patients who presented to the ED were first screened by an ED physician. If a potential HIV exposure was suspected, the ED physician contacted a physician affiliated with the HIV clinic (at any hour) for advice regarding initial investigations and an initial supply of ART to last until an anticipated HIV clinic appointment (usually 3-6 days). Verbal and written instructions were provided to patients providing followup information for their upcoming HIV clinic appointment, and they were provided with the clinic phone number for questions. Sexual assault survivors were also evaluated by a Sexual Assault Nurse Examiner (SANE) service and provided with additional psychosocial support in the ED and follow-up counseling. Patients who failed to attend clinic appointments were contacted via telephone and mail reminders. Voicemail messages were left on mobile phones if available (but not home phones owing to privacy issues), but no medical or confidential information was provided. Patients were contacted before completing the ART starter pack that was provided to them in the ED to avoid gaps in treatment between the ED and follow-up clinic appointment.
Patients who followed up in HIV clinic were reevaluated and PEP was continued, discontinued or changed based on further history and examination findings. Follow-up was performed at 2 and 4 weeks and at 3 and 6 months for safety laboratory testing, HIV screening, screening for other communicable infections (hepatitis B and C and sexually transmitted infections), pregnancy screening, and HIV risk counseling. The first-line regimen consisted of coformulated tenofovir and emtricitabine (Truvada), and was combined with lopinavir and ritonavir (Kaletra) if deemed appropriate by the treating physicians, according to guidelines and best practices. Raltegravir was substituted for lopinavir and ritonavir if there were drug interactions or side effects preventing adherence. All patients requiring nPEP had access to medications regardless of their insurance status through hospital-based short-term pharmacy programs or, if applicable, the state HIV Drug Assistance Program.
Outcomes
The primary outcome of this study was attendance at an initial HIV clinic appointment after an ED visit. Patients were categorized as clinic "no-shows" if they did not attend their initial HIV clinic appointment. Those who followed up elsewhere or followed up at the appropriate clinic but outside an appropriate window for nPEP continuation were not considered no-shows because they still had evaluation at a health care facility and access to screening and counseling. Our secondary outcome was the documented completion of a 28-day course of ART. Documented completion of ART was defined by patient self-report at follow-up appointments or through phone calls to patients, and was retrospectively evaluated via chart review. Patients were classified as having a documented completion of ART if they took more than 95% of the pills prescribed over the course of 28 days. Patients were categorized as having not completed their ART regimen if they were documented to take less than 95% of prescribed pills or had unknown adherence owing to both a lack of follow-up in subsequent clinic appointments and our inability to contact them by telephone and mail.
Data Collection and Analysis
Clinical and demographic data from patients who met entry criteria for this study were obtained through review of the electronic medical record and were sequentially entered in a database. We evaluated risk factors for failing to attend an initial HIV clinic appointment and ART noncompletion, including demographic data, HIV exposure type, day of the week of exposure (weekday vs weekend), time of day seen in the ED (regular work hours [8 AM to 5 PM] vs off hours [5 PM to 8 AM]), insurance status, and serostatus of the source patient. We compared clinical and demographic variables with patients' attendance at the HIV clinic, using Fisher exact test for categorical variables and the Student t test or Mann-Whitney U test for continuous variables, as guided by normality of the data. We calculated odds ratios (ORs) for attending HIV clinic, documented completion of a 28-day ART regimen, and then used multivariable logistic regression to assess independent predictors for these 2 outcomes. We performed an Allen-Cady modified, backward selection procedure, with sex and age included by default in all models [10] . We used a cutoff criterion of P = .20 for termination of variable elimination during backward selection. All tests for significance were 2 sided, with differences considered significant at P < .05. We calculated adjusted ORs (aORs) and 95% confidence intervals (CIs). Bivariable and multivariable analyses were performed using Stata software (version 11.0; StataCorp).
RESULTS
Descriptive Clinical Data and Bivariate Analysis
There were 198 individuals evaluated in the ED for whom the ED physician contacted the on-call HIV clinic physician for consideration of nPEP. Of these patients, 18 were deemed to represent either nonexposures not requiring nPEP or exposures with confirmed follow-up elsewhere, leaving 180 individuals who were to follow up in local clinics for nPEP care.
The median age of all individuals in this study was 28.0 years (interquartile range, 23-35 years), and 65.6% were women. The population was 70.6% white, 14.4% black, and 10.0% Hispanic. Just more than half (57.2%) of exposures were sexual. Of all sexual exposures, 72.0% were nonconsensual, and 22.1% were men who have sex with men. Of the nonsexual exposures, 17.8% were related to injection drug use, 40.0% were accidental needlestick injuries (eg, being stuck by a needle while taking out the garbage or stepping on a needle at the beach), and 42.2% were accidental mucous membrane or nonneedle percutaneous exposures (eg, exposures from bites, fights, or blood splashes). Most patients presented to the ED on weekdays, and they were equally distributed between day and evening/night shifts.
Of the 180 patients referred for nPEP, 98 (54.4%) attended the HIV clinic after their initial ED visit, and 82 (45.6%) did not return for follow-up ( Figure 1) ; 43 of 177 patients (24.3%) for whom continued nPEP was recommended had documentation for treatment completion.
Women were less likely to attend their initial HIV clinic appointment (OR, 0.48; 95% CI, .25-.91; Table 1 ). There were no differences in follow-up rates between racial groups or by day of the week or time of day of presentation to the ED. Twelve percent of patients reported a known HIV-positive source individual; these patients were more likely to attend their initial clinic appointment (OR, 3.23; 95% CI, 1.14-9.19). Of patients reporting sexual exposure, 72.0% reported nonconsensual exposure and were less likely to follow up at the clinic than those who did not report nonconsensual exposure (OR, 0.15; 95% CI, .05-.42). Similarly, the proportion of patients who did not return for follow-up was higher among those who had to pay out of pocket than among those with any form of coverage (OR, 0.22; 95% CI, .08-.64).
Independent Predictors for Clinic Follow-up and Drug Adherence
In a multivariable analysis, older age (aOR, 0.96; 95% CI, .93-.99) and self-payment (aOR, 0.32; 95% CI, .11-.97) were significant c Initially protected sexual exposures (ie, condoms were used at the onset of sexual exposure but either broke or were discontinued).
predictors for failing to attend an initial HIV clinic appointment ( Table 2) . No significant association was found for sex, known HIV-positive source patient, or nonconsensual sexual exposures. Women were less likely to have documented completion of a 28-day ART regimen (aOR, 0.34; 95% CI, .15-.79).
DISCUSSION
Simpler nPEP regimens with less drug interactions are available, however, poor follow-up and linkage to care persists. Our study demonstrates that a substantial proportion of patients are unaccounted for even before they present to an outpatient setting after their initial contact with an ED. We found that older patients and those without health insurance were significantly less likely to attend clinic for nPEP care after presenting to an ED with a potential HIV exposure. Other studies have illustrated poor clinic attendance and adherence to ART in patients once seen in an HIV clinic; although a recent meta-analysis reported ARV adherence rates higher than 77% [11] , it mainly included clinical trials in which funded additional staff could support counseling and follow-up activities, as opposed to busy EDs and HIV clinics, where nPEP follow-up is invariably reactive. This lack of follow-up has major implications for how care is delivered to patients presenting for nPEP. Our study demonstrates that patients who pay out of pocket are less likely to return for follow-up, a finding also seen in a recent study evaluating new diagnoses of HIV in an ED setting [12] . Although HIV transmission is relatively inefficient, nPEP can significantly reduce HIV transmission after an exposure [2, 3] . The follow-up clinic appointments are vital for enabling continuation of ART, encouraging drug adherence, modifying ART regimens in cases of significant toxicity, screening for other communicable and noncommunicable conditions, and counseling. HIV clinics provide expertise and dedicated risk-reduction counseling, and studies evaluating patients in both nPEP [3] and preexposure prophylaxis [13, 14] settings demonstrate that patients do not engage in higher-risk sexual behavior after accessing these HIV prevention modalities. Still, these data are from clinical trial settings with more counseling resources available to patients, and the impact of these modalities on behavioral changes in "real-world" settings is still unknown. The high attrition rates from the ED to clinic demonstrated in our current study are very concerning, given the high value that the clinic setting offers.
Our study also found that women accounted for the vast majority of nonconsensual sexual exposures, and the multivariable analysis demonstrated that they were significantly less likely to have documented completion of their 28-day ART regimen. These results indicate that sexual assault victims are missing appointments and therapy that are geared to provide crucial medical and psychosocial support. Other studies have also reported high rates of loss to follow-up among sexual assault victims in clinic settings [15] [16] [17] [18] , and, unfortunately, targeted interventions such as telephone psychosocial support have not been successful in ameliorating these poor clinic attendance rates [19] . In addition, clinic dropout rates seem to increase with time, and only about half of patients attend their 3 month follow-up, with significantly fewer keeping subsequent appointments [20, 21] . Our findings demonstrate that this dropout trend begins before patients present for their first clinic appointment, despite immediate provision of an appointment time and clinic outreach efforts. A study assessing newly diagnosed HIV in an ED setting using rapid tests showed clinic follow-up rates similar to those in our study, with only 50% of patients linking to care 30 days after the ED visit [12] . Even more concerning is the limited time window for nPEP care to be effective [22] ; long interruptions in ART use between an ED visit and clinic appointment may diminish the efficacy of nPEP.
Our study cohort is unique in that it includes a diverse representation of major categories of nPEP such as men who have sex with men, sexual assault survivors, and nonsexual exposures. A disadvantage is that each exposure group was relatively small, given the total sample size of 180 patients, limiting our power to detect associations with a particular risk. We found that individuals with exposure to a known HIV-positive source individual were more likely to attend their initial clinic appointment. It is possible that higher perceived risk, by patients or by clinicians, may influence follow-up rates; future qualitative studies could further clarify the importance of risk perception and risk framing in nPEP completion. In addition, we may have overestimated the number of patients who failed to attend follow-up HIV clinic appointments because they may have received follow-up care elsewhere, even when we were not able to contact them by telephone or mail for confirmation. Documented ART completion was measured retrospectively and by history, which is less accurate than pill counts and may overestimate drug adherence by as much as 20% [20, 21] . We were unable to assess degrees of adherence in further detail owing to the dichotomous threshold of 95% adherence that was used in the clinic's reporting system. The 95% adherence cutoff may not be relevant for regimens consisting of protease inhibitors with long half-lives, for which missing a dose is probably insignificant, but strict adherence may be more important with raltegravircontaining regimens, for which once-daily dosing is inferior to twice-daily dosing [23] . In addition, documented nPEP completion may be underestimated because we did not count individuals who were provided with ART but failed to show up to subsequent clinic appointments, despite our best efforts to contact them. These individuals could conceivably be adherent to ART and still not follow up at the clinic. The commonly used model of care for nonoccupational HIV exposures in the ED-providing an ART starter pack with subsequent follow-up in the clinic-may not provide adequate protection for vulnerable populations. Those who pay out of pocket often fail to attend their initial clinic appointment. Sexual assault victims also seem to have frequent loss to follow-up. Similarly, we demonstrated that sexual assault victims have poor documented completion of their 28-day ART regimen. Taken together, these results suggests that a "one-size-fits-all" model for nPEP is probably not effective for marginalized populations.
There are several other models for providing nPEP care, each with significant benefits and drawbacks. One potential model is for primary care providers (PCPs) to deliver all nPEP care. PCPs may already have an existing relationship with a patient, which may reduce the risk of loss to follow-up, particularly after the trauma of sexual assault. Many clinics, however, do not have the capacity or expertise to provide counseling for cohorts such as sexual assault victims and may not be able to provide immediate care for the physical trauma that accompanies these exposures. Models to enhance communication support for PCPs from infectious disease and HIV consultants might ameliorate some of these deficits. In addition, many patients do not have a PCP for follow-up. An alternative model would be for patients presenting to an ED to be provided with longer ART start-up packages (free of charge), ranging from 14 to 28 days rather than the traditional 3-6 days. Such intervention may reduce costs to those who pay out of pocket, and perhaps decrease the risks of gaps in care between the ED and clinic. Although not ideal, such a system may also give patients an opportunity to take nPEP even if they do not adhere to scheduled clinic follow-up, but it runs the risk of missing medicationassociated adverse events and important screening and counseling in the clinic. Tailoring care to specific exposures types and individuals may provide improved adherence in those specifically identified subgroups. For example, in those who cannot afford nPEP and have no medical insurance, adherence to ART and appointments may be increased if clinics, local public health units, or local governments covered the initial costs of nPEP and follow-up care in selected individuals.
Our prospective cohort study demonstrates significant attrition rates between the ED and HIV clinic in patients suffering HIV exposures. Future work should evaluate strategies targeted to high-risk groups, including women and uninsured patients, to enable adherence to clinic appointments and ART. Qualitative and quantitative studies focusing on the individual patients' nPEP experience from presentation to completion of screening may inform potential methods to bridge gaps in care.
